eScholarshipmetadata only
An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease
32 biomedical and clinical sciences (for-2020), 3204 immunology (for-2020), prevention (rcdc), infectious diseases (rcdc), biodefense (rcdc), biotechnology (rcdc), emerging infectious diseases (rcdc), rare diseases (rcdc)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 1052765
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.